Die septische Enzephalopathie stellt eine pathophysiologisch komplexe Hirnfunktionsstörung septischer Patienten dar. Ihr Schweregrad korreliert mit der Mortalität. Häufig ist die Enzephalopathie das Erstsymptom einer Infektionserkrankung. Aufgrund dieser Tatsache und der bis heute fehlenden spezifischen Therapieoptionen ist eine frühe Erkennung mit der Chance einer umgehenden antimikrobiellen Behandlung sowie die differenzialdiagnostische Abgrenzung gegenüber anderen Ursachen eines Enzephalopathie-Syndromes entscheidend.
Literatur
Karl Eibl: Johann Wolfgang Goethe. Samtliche Werke, Briefe, Tagebucher und Gesprache, Bd. 2. Deutscher Klassiker-Verlag: 1987, S. 107-108
Vincent JL, Sakr Y, Sprung CL et al Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344–53
Singer M, Deutschman CS, Seymour CW et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10
Chaudhry N, Duggal AK. Sepsis Associated Enzephalopathy. Adv Med. 2014;2014:762320. doi: 10.1155/2014/762320
Eidelman LA, Putterman D, Putterman C, Sprung CL. The spectrum of septic enzephalopathy. Definitions, etiologies, and mortalities. JAMA. 1996;275(6):470–3
Sonneville R, Verdonk F, Rauturier C et al. Understanding brain dysfunction in sepsis. Ann Intensive Care. 2013;3(1):15
Papadopoulos MC, Lamb FJ, Moss RF et al. Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin Sci (Lond). 1999;96(5):461–6
Londono D, Cadavid D. Bacterial lipoproteins can disseminate from the periphery to inflame the brain. Am J Pathol. 2010;176(6):2848–57
Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-alpha. Nature. 2006;440(7087):1054–9
Semmler A, Okulla T, Sastre M et al. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat. 2005;30(2-3):144–57
Tsuruta R, Oda Y. A clinical perspective of sepsis-associated delirium. J Intensive Care. 2016;4:18
Barr J, Fraser GL, Puntillo K et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306
Hosokawa K, Gaspard N, Su F et al. Clinical neurophysiological assessment of sepsis-associated brain dysfunction: a systematic review. Crit Care. 2014;18(6):674
Young GB, Bolton CF, Archibald YM et al. The electroenzephalogram in sepsis-associated enzephalopathy. J Clin Neurophysiol. 1992;9(1):145–52
Azabou E, Magalhaes E, Braconnier A et al. Early Standard Electroenzephalogram Abnormalities Predict Mortality in Septic Intensive Care Unit Patients. PLoS One. 2015;10(10):e0139969
Pierrakos C, Antoine A, Velissaris D et al. Transcranial doppler assessment of cerebral perfusion in critically ill septic patients: a pilot study. Ann Intensive Care. 2013;3:28
Yao B, Zhang LN, Ai YH et al. Serum S100β is a better biomarker than neuron-specific enolase for sepsis-associated enzephalopathy and determining its prognosis: a prospective and observational study. Neurochem Res. 2014;39(7):1263–9
Ziaja M. Septic enzephalopathy. Curr Neurol Neurosci Rep. 2013;13(10):383
Stubbs DJ, Yamamoto AK, Menon DK. Imaging in sepsis-associated enzephalopathy—insights and opportunities. Nat Rev Neurol. 2013;9(10):551–61
Dellinger RP, Levy MM, Rhodes A et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637
Sui DM, Xie Q, Yi WJ et al. Resveratrol Protects against Sepsis-Associated Enzephalopathy and Inhibits the NLRP3/IL-1β Axis in Microglia. Mediators Inflamm. 2016;2016:1045657. doi: 10.1155/2016/1045657
Flierl MA, Stahel PF, Rittirsch D et al. Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis. Crit Care. 2009;13(1):R12
Toklu HZ, Uysal MK, Kabasakal L et al. The effects of riluzole on neurological, brain biochemical, and histological changes in early and late term of sepsis in rats. J Surg Res. 2009;152(2):238–48
Ranieri VM, Thompson BT, Barie PS et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012;366(22):2055–64
Burkhart CS, Dell-Kuster S, Siegemund M et al. Effect of n-3 fatty acids on markers of brain injury and incidence of sepsis-associated delirium in septic patients. Acta Anaesthesiol Scand. 2014;58(6):689–700
Page VJ, Davis D, Zhao XB et al. Statin use and risk of delirium in the critically ill. Am J Respir Crit Care Med. 2014;189(6):666–73
Morandi A, Hughes CG, Thompson JL et al. Statins and delirium during critical illness: a multicenter, prospective cohort study. Crit Care Med. 2014;42(8):1899–909
Page VJ, Ely EW, Gates S et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2013;1(7):515–23. Erratum in: Lancet Infect Dis. 2014;14(11):1040
Pandharipande PP, Sanders RD, Girard TD et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care. 2010;14(2):R38
Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787–94
Semmler A, Widmann CN, Okulla T et al. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J Neurol Neurosurg Psychiatry. 2013;84(1):62–9
Götz T, Günther A, Witte OW et al. Long-term sequelae of severe sepsis: cognitive impairment and structural brain alterations - an MRI study (LossCog MRI). BMC Neurol. 2014;14:145
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lerch, S. Septische Enzephalopathie. CV 16, 41–45 (2016). https://doi.org/10.1007/s15027-016-0999-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15027-016-0999-3